{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:02:56Z","timestamp":1760043776665},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T00:00:00Z","timestamp":1243555200000},"content-version":"vor","delay-in-days":820,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Programme completion is predictive of post\u2010treatment abstinence and other improvements in persons with opioid dependence, while continued agonist treatment is associated with better outcomes than no agonist treatment. This study aimed to assess relationships between follow\u2010up outcomes of a 9\u2010month buprenorphine programme, completion and current agonist therapy status. Sixty\u2010eight of 75 opioid\u2010dependent former participants were assessed at study entry and 24 months thereafter. Outcome measures were opioid abstinence, substance use and psychosocial performance. Group comparisons were made between buprenorphine programme completers (<\/jats:italic>n <jats:italic>= 38) and non\u2010completers (<\/jats:italic>n <jats:italic>= 30), and between participants who were currently in agonist therapy (<\/jats:italic>n <jats:italic>= 37) and those who were not. Performance at follow\u2010up was compared to that at study entry. Nine people were abstinent from all opioids at follow\u2010up. Completers and non\u2010completers were similar in follow\u2010up performance and patterns of change, while participants' current agonist therapy status was related to both substance use and psychosocial outcomes. Reductions in street opioid use and injecting were seen regardless of completion and agonist therapy status. Retaining patients in agonist replacement therapy over time is more likely than completion of a time\u2010limited programme to influence long\u2010term outcomes. Time\u2010limited buprenorphine replacement therapy appears to be inappropriate for persons with opioid dependence<\/jats:italic><\/jats:p>","DOI":"10.1080\/09595230601146603","type":"journal-article","created":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T06:38:04Z","timestamp":1175236684000},"page":"135-141","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Time\u2010limited buprenorphine replacement therapy for opioid dependence: 2\u2010year follow\u2010up outcomes in relation to programme completion and current agonist therapy status"],"prefix":"10.1111","volume":"26","author":[{"given":"HEGE","family":"KORN\u00d8R","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HELGE","family":"WAAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEIV","family":"SANDVIK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,5,29]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.931738.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00227.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00211-8"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.10.1303"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826089409048714"},{"key":"e_1_2_1_7_2","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane Review)","author":"Mattick RP","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_1_8_2","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence (Cochrane Review)","author":"Mattick RP","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826087309033105"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jama.1973.03230070013002","article-title":"Detoxification of rehabilitated methadone\u2010maintained patients","volume":"226","author":"Cushman P.","year":"1973","journal-title":"JAMA"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1978.tb16774.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1981.tb12812.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500170241"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198807000-00003"},{"key":"e_1_2_1_15_2","first-page":"62","article-title":"Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored","volume":"68","author":"Magura S.","year":"2001","journal-title":"Mt Sinai J Med"},{"key":"e_1_2_1_16_2","volume-title":"For\u2010skrivning og forsvarlighet. IK\u20102755","author":"Norwegian Board of Health.","year":"2001"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500537209"},{"key":"e_1_2_1_18_2","volume-title":"The ICD\u201010 classification of mental and behavioural disorders, clinical description and diagnostic guidlines","author":"World Health Organisation.","year":"1992"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"e_1_2_1_20_2","volume-title":"European Addiction Severity Index (EuropASI). Cost A6","author":"Kokkevi A.","year":"1994"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/bs.3830190102"},{"key":"e_1_2_1_22_2","unstructured":"SPSS Inc. SPSS for Windows version 11.0. Chicago: SPSS Inc. 2001."},{"key":"e_1_2_1_23_2","volume-title":"Age\u2010specific death rates for males and females, 1971\u20132005"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00028-3"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826089609063969"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.01.006"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(86)90019-X"},{"key":"e_1_2_1_28_2","volume-title":"A prospective study of drug abusers in treatment]","author":"Melberg HO","year":"2003"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952998209002616"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4603(00)00174-X"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(97)00308-5"},{"key":"e_1_2_1_32_2","first-page":"101","article-title":"Phase II clinical trials of buprenorphine: detoxification and induction onto nal\u2010trexone","volume":"121","author":"Kosten TR","year":"1992","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770280111012"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.13"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F09595230601146603","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F09595230601146603","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/09595230601146603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T18:50:47Z","timestamp":1699987847000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/09595230601146603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1080\/09595230601146603"],"URL":"https:\/\/doi.org\/10.1080\/09595230601146603","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"2009-05-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}